Resistance of SOD-Transgenic Mice to Oxidative Stress

charles j epstein,pak h chan,jean lud cadet,elaine carlson,s chen,ling chu,stanley fahn,vernice jacksonlewis,hiroyuki kinouchi,vladimir s kostic,kayoko kujirai,a mizui,ali b naini,serge przedborski,guangyou yang
DOI: https://doi.org/10.1007/978-3-642-84842-1_9
1992-01-01
Abstract:The activity of CuZn-superoxide dismutase (CuZnSOD) in the brain and other tissues of mice has been increased between 1.5- and 5-fold by the insertion of one or more human CuZnSOD transgenes into the mouse genome. Although physically normal, these transgenic mice exhibit several differences from control mice when exposed to known or presumed forms of oxidative stress. After a 30-second cold injury to the cerebral cortex, transgenic mice with approximately 3-times normal CuZnSOD activity have less cerebral edema, a smaller increase in vascular permeability, and a smaller area of infarction than do the control animals. These transgenic animals are also protected to a significant degree against the effects of transient focal cerebral ischemia in the middle cerebral artery distribution, with sparing particularly of the penumbra region surrounding the ischemic brain tissue. Furthermore, in contrast to control animals, the injection of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) into transgenic mice does not induce any depletion in striatal levels of dopamine and its metabolites or decreases in dopamine uptake sites. MPTP is an agent which causes changes in the dopaminergic system similar to those observed in Parkinson’s disease. Cultured primary cortical neurons from transgenic fetuses demonstrate a significant reduction in the toxic effects of exposure to 0.5 mM glutamate.
What problem does this paper attempt to address?